Robinul vs. Cuvposa

Are Robinul and Cuvposa the Same Thing?

Robinul Injection (glycopyrrolate) and Cuvposa (glycopyrrolate) are anticholinergics that help to control conditions such as peptic ulcers that involve excessive stomach acid production.

The injectable form of Robinul is also used to reduce saliva, nasal, lung, and stomach.

Cuvposa is also used to reduce drooling in children ages 3 to 16 who have certain medical conditions, such as cerebral palsy.

Side effects of Robinul and Cuvposa that are similar include drowsiness, dizziness, blurred vision, dry mouth, vomiting, constipation, stuffy nose, sinus pain, or flushing (warmth, redness, or tingly feeling).

Side effects of Robinul that are different from Cuvposa include weakness, dry eyes, or abdominal bloating.

Both Robinul and Cuvposa may interact with alcohol or amantadine.

Robinul may also interact with quinidine, antihistamines, decongestants, appetite suppressants, phenothiazines, or antidepressants.

Cuvposa may also interact with atenolol, digoxin, haloperidol, levodopa, or metformin.

What Are Possible Side Effects of Robinul?

Common side effects of Robinul include:

  • drowsiness,
  • dizziness,
  • weakness,
  • blurred vision,
  • dry eyes,
  • dry mouth,
  • vomiting,
  • constipation,
  • abdominal bloating,
  • stuffy nose,
  • sinus pain, or
  • flushing (warmth, redness, or tingly feeling).

Tell your doctor if you experience unlikely but serious side effects of Robinul Injection including:

  • decreased sweating,
  • fast/irregular heartbeat,
  • mental/mood changes (such as confusion, hallucinations, agitation, nervousness, unusual excitement),
  • difficulty urinating, or
  • decreased sexual ability.

What Are Possible Side Effects of Cuvposa?

Common side effects of Cuvposa include:

  • drowsiness,
  • dizziness,
  • blurred vision,
  • dry mouth,
  • stuffy nose,
  • sinus pain,
  • constipation,
  • vomiting, or
  • flushing (warmth, redness, or tingly feeling).

Tell your doctor if you have serious side effects of Cuvposa including:

  • stomach or abdominal bloating or pain,
  • persistent constipation,
  • persistent nausea or vomiting,
  • diarrhea,
  • decreased sweating,
  • fast or irregular heartbeat,
  • mental/mood changes (such as confusion, hallucinations, agitation, nervousness, unusual excitement), or
  • difficulty urinating or inability to urinate.

What Is Robinul?

Robinul Injection (glycopyrrolate) is an anticholinergic that helps to control conditions such as peptic ulcers that involve excessive stomach acid production. The injectable form of Robinul is also used to reduce saliva, nasal, lung, and stomach secretions and to help control heart rate during surgery. Robinul Injection is available in generic form.

What Is Cuvposa?

Cuvposa (glycopyrrolate) Oral Solution is an anticholinergic drug used to control conditions such as peptic ulcers that involve excessive stomach acid production. Cuvposa is also used to reduce drooling in children ages 3 to 16 who have certain medical conditions, such as cerebral palsy.

SLIDESHOW

Super Tips to Boost Digestive Health: Bloating, Constipation, and More See Slideshow

What Drugs Interact With Robinul?

Robinul may interact with amantadine, quinidine, antihistamines, decongestants, appetite suppressants, phenothiazines, or antidepressants. Tell your doctor all prescription and over-the-counter medications you use. During pregnancy, Robinul should be used only when prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

What Drugs Interact With Cuvposa?

Cuvposa may interact with amantadine, atenolol, digoxin, haloperidol, levodopa, or metformin. Tell your doctor all medications and supplements you use. During pregnancy, Cuvposa should be used only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

How Should Robinul Be Taken?

Robinul injection is administered intramuscularly (IM) or intravenously (IV), under a physician's supervision. Dose depends on the condition being treated.

How Should Cuvposa Be Taken?

The initial dose of Cuvposa is 0.02 mg/kg orally three times daily, and then adjusted in increments of 0.02 mg/kg every 5-7 days based on the patient's response and adverse reactions. The maximum recommended dosage is 0.1 mg/kg three times daily not to exceed 1.5-3 mg per dose based upon weight.

QUESTION

Pancreatitis is inflammation of an organ in the abdomen called the pancreas. See Answer
Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
SOURCE:

Mylan. Glycopyrrolate (Robinul) Product Information.

https://www.mylan.com/en/products/product-catalog/product-profile-page?id=402197af-c04e-455a-9eed-c1249f187dc7

Merz Pharmaceuticals, LLC. Cuvposa Product Information.

https://www.cuvposa.com/

Health Solutions From Our Sponsors